01.12.2021 18:30:57

What’s Next For Merck Stock After FDA Advisors Back Its Covid-19 Pill?

Just a few days back we discussed that the stock price of Merck is being weighed down due to concerns around its Covid-19 antiviral pill - Molnupiravir - which has an efficacy of 30% against hospitalization and death in high-risk patients. Yesterday, a panel of advisors to the U.S. FDA voted in...
Weiter zum vollständigen Artikel bei "Forbes"